ASSOCIATION OF CELIAC DISEASE IN PATIENTS WITH TYPE 1.5 DIABETES MELLITUS: LITERATUR REVIEW
Keywords:
Celiac disease, Diabetes, Autoimmunity, LADA/T1.5DMAbstract
Background: Celiac disease (CD) and type 1 diabetes are immune-mediated diseases that share common susceptibility factors, primarily HLA genetics.
Objective and methods: This systematic review and meta-analysis sought data from Cochrane, PubMed, Googlescholar, and other journal databases. We searched for the keywords “celiac disease” and “diabetes melitus”. The inclusion criteria of the research to be included are research that examines the association of celiac disease in patients with type 1.5 diabetes melitus or latent autoimmune diabetes in adults (LADA), research subjects are adults (not animal), and use primary data.
Result: All the studies found showed a close association between celiac disease and LADA or T1.5DM.
Conclusion: LADA or type 1.5 DM and CD are autoimmune conditions that can coexist. HLA is a gene that plays a role in both diseases. Clear common risk factors, genetics and environment are likely to play an important role in the initiation of the condition.
References
International Diabetes Federation. Diabetes. Brussels: IDF; 2015.
American Diabetes Association. Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 2016;62–9.
Kasper; Denis L; et al. Harrison’s Principles of Internal Medicine 19th Edition. New York: McGraw-Hill Education; 2018.
Cohn A, Sofia MA, Kupfer SS. Type 1 Diabetes and Celiac Disease: Clinical Overlap and New Insights into Disease Pathogenesis. Curr Diab Rep. 2014;14(8):517–21.
Tye-Din JA, Galipeau HJ, Agardh D. Celiac Disease: A Review of Current Concepts in Pathogenesis, Prevention, and Novel Therapies. Front Pediatr. 2018;6:350–7.
Kaur N, Bhadada SK, Minz RW, et al. Diabetes Mellitus and Celiac Disease: Implications in Treatment. Karger Publ. 2018;36(6):399–408.
Sanchez JC, Cabrera-Rode E, Sorell L, et al. Celiac disease associated antibodies in persons with latent autoimmune diabetes of adult and type 2 diabetes. Autoimmun Rev. 2007;40(2):103–7.
Kylokas A, Kaukinen K, Huhtala H, et al. Type 1 and type 2 diabetes in celiac disease: prevalence and effect on clinical and histological presentation. BMC Gastroenterol. 2016;16(76):109–17.
Oujamaa I, Sebbani M, Elmoumou L, et al. The Prevalence of Celiac Disease-Specific Auto-Antibodies in Type 1 Diabetes in a Moroccan Population. Int J Endocrinol. 2019;28(7):89–97.
Washeim M, Diana L. Type 1 Diabetes and Celiac Disease. Clin Nutr. 2006;21(4):341–54.
Al-Toma A, Volta U, Auricchio R, et al. European Society for the Study of Coeliac Disease (ESsCD) guideline for coeliac disease and other gluten-related disorders. United Eur Gastroenterol J. 2019;
Kliegman R. M; et al. Nelson Textbook of Pediatrics. Philadelphia: Elsevier Saunder; 2016.
Hansen D, Brock-Jacobsen B, Lund E, et al. Clinical benefit of a gluten-free diet in type 1 diabetic children with screening-detected celiac disease: a population-based screening study with 2 years’ follow-up. Diabetes Care. 2006;29(11):2452–6.
Miranda J, Lasa A, Bustamante MA, et al. Nutritional differences between a gluten-free diet and a diet containing equivalent products with gluten. Plant Foods Hum Nutr. 2014;69(2):182–7.
Rubio-Tapia A, Hill ID, Kelly CP, et al. ACG clinical guidelines: diagnosis and management of celiac disease. Am J Gastroenterol. 2013;108(5):656–72.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Licensing
Ninety Nine Publication publishes articles under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This licensing allows for any use of the work, provided the original author(s) and source are credited, thereby facilitating the free exchange and use of research for the advancement of knowledge.
Detailed Licensing Terms
Attribution (BY): Users must give appropriate credit, provide a link to the license, and indicate if changes were made. Users may do so in any reasonable manner, but not in any way that suggests the licensor endorses them or their use.
No Additional Restrictions: Users may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
